Heart failure drug tested for hidden benefits beyond the heart
NCT ID NCT05420012
Summary
This study tested whether the heart failure drug vericiguat improves the health of blood vessels and reduces body-wide inflammation in patients. It involved 26 adults with chronic heart failure who were already on standard treatments. Researchers measured blood vessel function, walking ability, and quality of life to see if the drug helps in ways beyond just the heart muscle.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEART FAILURE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
University of Utah Hospital
Salt Lake City, Utah, 84132, United States
-
Veterans Affairs Salt Lake City Health Care System (VAMC)
Salt Lake City, Utah, 84148, United States
Conditions
Explore the condition pages connected to this study.